Inventor
Qi Huang
Inventor
Moorpark, CA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
Y02ATechnologies for adaptation to climate change4%
C07KPeptides3%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
C04BLime, magnesia1%
C07CAcyclic or carbocyclic compounds1%
G02BOptical elements, systems or apparatus1%
PatentTitleYear
11,022,766Adapter2021RE047475Selective agents for pain suppression201910,196,3592-alkyloxy benzene formyl arylamine compound and pharmaceutical use thereof20199,723,838'Pyrazolyl amide compounds and uses thereof'20178,722,896'Prokineticin receptor antagonists and uses thereof'20148,686,011'Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1'20148,642,624'Substituted alkylamine derivatives and methods of use'20148,557,830'RAF kinase modulators and methods of use'20138,541,592'Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1'20138,440,674'Substituted pyrimidine compounds as RAF inhibitors and methods of use'20138,288,351'Antagonists of the bradykinin B1 receptor'20128,278,280'Antagonists of the bradykinin B1 receptor'20127,807,700'Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1'20107,662,811'1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use'20107,514,564'Substituted amine derivatives and methods of use'20097,307,088'Substituted anthranilic amide derivatives and methods of use'20077,253,196'Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1'20077,235,656'Anxiolytic agents with reduced sedative and ataxic effects'20077,119,196'Anxiolytic agents with reduced sedative and ataxic effects'20067,119,111'2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use'20067,105,682'Substituted amine derivatives and methods of use'20067,102,009'Substituted amine derivatives and methods of use'20067,101,868'Substituted arylamine derivatives and methods of use'20066,995,162'Substituted alkylamine derivatives and methods of use'20066,878,714'Substituted alkylamine derivatives and methods of use'20056,849,639'Integrin inhibitors and their methods of use'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2014Patents assigned to AMGEN INC (18)· patent assignee history
2005–2014Based in Moorpark, CA, US· patent location history
2007–2014Patents assigned to BIOVITRUM AB (3)· patent assignee history
2012–2014Patents assigned to HUANG QI (8)· patent assignee history
2013–2014Patents assigned to CAI GUOLIN (3)· patent assignee history
2013–2014Patents assigned to YUAN CHESTER CHENGUANG (3)· patent assignee history
2017Based in Liaoning, CN· patent location history
2019Based in Camarillo, CA, US· patent location history
2019Based in Shanghai, CN· patent location history
2021Based in Anhui, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 18 | 2005–2014 |
| HUANG QIself | 8 | 2012–2014 |
| BIOVITRUM AB | 3 | 2007–2014 |
| CAI GUOLIN | 3 | 2013–2014 |
| YUAN CHESTER CHENGUANG | 3 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Moorpark, California, US | 21 | 2005–2014 |
| Anhui, CN | 1 | 2021 |
| Camarillo, California, US | 1 | 2019 |
| Shanghai, CN | 1 | 2019 |
| Liaoning, CN | 1 | 2017 |